Aim Little is known about whether one of these agents has superiority over the other in attenuating hemodynamic responses associated with tracheal in tubation. This paper aims to compare the effects of intravenous injection of low-dose esmolol, magnesium sulfate, and placebo on hemodynamic responses associated with endotracheal intubation. Methods Sixty patients receiving elective spine surgery were randomized into three groups: esmolol group (E; 0.2 mg/kg bolus, 3 mg/kg/h infu sion thereafter), magnesium sulfate group (M; 30 mg/kg bolus, 10 mg/kg/h infusion thereafter), or control (placebo) group (C). Heart rate (HR), mean arterial pressure (MAP), and systolic (SBP), and diastolic blood pressure (DBP) were recorded at baseline, after induction, intubation, prone positioning, skin incision, supine positioning, and at recovery. Differences in HR, MAP, SBP, and DBP in the three groups during anesthesia and recovery were the most important result of this work. Results HR, MAP, SBP, and DBP were similar in all groups following endotracheal intubation. Hypotension occurred in three patients in group M at the end of anesthesia when they were repositioned to the supine position. On the other hand, neither group E nor group C experienced hypotension (p=0.043). Bradycardia (HR < 50 bets/min) was observed in six patients in group M, in four patients in group E, and one patient in group C when the patients were placed in the prone position (p=0.043). Aim: Little is known about whether one of these agents has superiority over the other in attenuating hemodynamic responses associated with tracheal in tubation. This paper aims to compare the effects of intravenous injection of low-dose esmolol, magnesium sulfate, and placebo on hemodynamic responses associated with endotracheal intubation. Material and Methods: Sixty patients receiving elective spine surgery were randomized into three groups: esmolol group (E; 0.2 mg/kg bolus, 3 mg/kg/h infu sion thereafter), magnesium sulfate group (M; 30 mg/kg bolus, 10 mg/kg/h infusion thereafter), or control (placebo) group (C). Heart rate (HR), mean arterial pressure (MAP), and systolic (SBP), and diastolic blood pressure (DBP) were recorded at baseline, after induction, intubation, prone positioning, skin incision, supine positioning, and at recovery. Differences in HR, MAP, SBP, and DBP in the three groups during anesthesia and recovery were the most important result of this work. Results: HR, MAP, SBP, and DBP were similar in all groups following endotracheal intubation. Hypotension occurred in three patients in group M at the end of anesthesia when they were repositioned to the supine position. On the other hand, neither group E nor group C experienced hypotension (p=0.043). Bradycardia (HR < 50 bets/min) was observed in six patients in group M, in four patients in group E, and one patient in group C when the patients were placed in the prone position (p=0.043). Conclusion Our findings show that 30 mg/kg magnesium sulfate and 0.2 mg/kg esmolol boluses and infusions (30 mg/kg bolus and 10 mg/kg/h, respectively) were not more effective than placebo in the prevention of the hemodynamic variations after endotracheal intubation. Higher magnesium sulfate and esmolol doses may blunt elevated heart rate and blood pressure following endotracheal intubation.